{"id":"https://openalex.org/W34518040","doi":null,"title":"Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.","display_name":"Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.","publication_year":1999,"publication_date":"1999-07-01","ids":{"openalex":"https://openalex.org/W34518040","mag":"34518040","pmid":"https://pubmed.ncbi.nlm.nih.gov/10470187"},"language":"en","primary_location":{"id":"pmid:10470187","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10470187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110171355","display_name":"A. van Dalen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141521","display_name":"Groene Hart Ziekenhuis","ror":"https://ror.org/0582y1e41","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210141521"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A van Dalen","raw_affiliation_strings":["Groene Hart Ziekenhuis, Gouda, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groene Hart Ziekenhuis, Gouda, The Netherlands","institution_ids":["https://openalex.org/I4210141521"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J Favier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Favier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085758126","display_name":"L Baumgartner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Baumgartner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065000478","display_name":"Ute Hasholzner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U Hasholzner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010033881","display_name":"Hwa de Bruijn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H de Bruijn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020249420","display_name":"D Dobbler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Dobbler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046129275","display_name":"V H Dombi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V H Dombi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114006726","display_name":"D. Fink","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Fink","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108104453","display_name":"Maurizia Giai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Giai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112718887","display_name":"Peter G. McGing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P McGing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045076211","display_name":"Antonina Harlozinska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Harlozinska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003887304","display_name":"Ch. Kainz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Kainz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055469385","display_name":"Janina Markowska","orcid":"https://orcid.org/0000-0002-2893-8389","observed_orcids":["https://orcid.org/0000-0002-2893-8389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Markowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045940617","display_name":"Raquel Molina","orcid":"https://orcid.org/0000-0002-3744-2836","observed_orcids":["https://orcid.org/0000-0002-3744-2836"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Molina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111582970","display_name":"Catherine Sturgeon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Sturgeon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007727912","display_name":"Roland EINARSSON","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Einarsson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3473,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.57911079,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"19","issue":"4A","first_page":"2523","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ca125","display_name":"CA125","score":0.9309999942779541},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7419999837875366},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cytoreductive-surgery","display_name":"cytoreductive surgery","score":0.7390000224113464},{"id":"https://openalex.org/keywords/tumor-stage","display_name":"tumor stage","score":0.5199999809265137},{"id":"https://openalex.org/keywords/serum-tumor-markers","display_name":"serum tumor markers","score":0.6140000224113464},{"id":"https://openalex.org/keywords/cutoff-values","display_name":"cut-off values","score":0.5059999823570251},{"id":"https://openalex.org/keywords/staging-laparotomy","display_name":"staging laparotomy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/histological-grade","display_name":"histological grade","score":0.4860000014305115},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.6460000276565552},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy-duration","display_name":"adjuvant chemotherapy duration","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7454940676689148},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.6737604141235352},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6468988060951233},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6366026401519775},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6184839010238647},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5822771787643433},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4667288064956665},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4552222490310669},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.4120733141899109},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4075477719306946},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3858455419540405},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1582258939743042},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011933","descriptor_name":"Reagent Kits, Diagnostic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018394","descriptor_name":"CA-125 Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmid:10470187","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10470187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/cd880ee4-4e4a-44f5-8e8a-36550b373241","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/cd880ee4-4e4a-44f5-8e8a-36550b373241","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Van Dalen, A, Favier, J, Baumgartner, L, Hasholzner, U, De Bruijn, H, Dobbler, D, Dombi, VH, Fink, D, Giai, M, McGing, P, Harlozinska, A, Kainz, C, Markowska, J, Molina, R, Sturgeon, C & Einarsson, R 1999, 'Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients', Anticancer Research, vol. 19, no. 4A, pp. 2523-2526.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/cd880ee4-4e4a-44f5-8e8a-36550b373241","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/cd880ee4-4e4a-44f5-8e8a-36550b373241","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Anticancer Research, 19(4A), 2523 - 2526. INT INST ANTICANCER RESEARCH","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:34518040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10470187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1839804704","https://openalex.org/W1926654776","https://openalex.org/W1972341325","https://openalex.org/W1986241711","https://openalex.org/W1992423599","https://openalex.org/W2044049838","https://openalex.org/W2047073318","https://openalex.org/W2058730747","https://openalex.org/W2066050590","https://openalex.org/W2066411968","https://openalex.org/W2066972686","https://openalex.org/W2122805783","https://openalex.org/W2141748269","https://openalex.org/W2161675417","https://openalex.org/W2186647900","https://openalex.org/W2257573908","https://openalex.org/W2287840388","https://openalex.org/W2289331770","https://openalex.org/W2306952105","https://openalex.org/W2321587450","https://openalex.org/W2328623642","https://openalex.org/W2343653292","https://openalex.org/W2535284666","https://openalex.org/W2570732803","https://openalex.org/W2766345363","https://openalex.org/W2780090036","https://openalex.org/W2794791626","https://openalex.org/W2807960603","https://openalex.org/W2894013039","https://openalex.org/W2913848848","https://openalex.org/W2972936715","https://openalex.org/W2999585526","https://openalex.org/W3008313240"],"related_works":["https://openalex.org/W40829566","https://openalex.org/W2104774477","https://openalex.org/W139179242","https://openalex.org/W2424474678","https://openalex.org/W1973937649","https://openalex.org/W2102408026","https://openalex.org/W2054867327","https://openalex.org/W2296954397","https://openalex.org/W2029112222","https://openalex.org/W1981180195"],"abstract_inverted_index":{"The":[0,229,275,308],"analysis":[1,37,194],"of":[2,5,104,112,120,130,155,167,177,195,202,213,219,232,255,294],"survival":[3,33,36,246,291],"data":[4],"patients":[6,45,94,105,132,157,169,178,215,221,257,296,313],"with":[7,46,89,106,135,160,179,223,245,264,287,297,314,334],"epithelial":[8],"ovarian":[9],"cancer":[10],"proved":[11],"that":[12],"both":[13],"CA":[14,65,113,123,136,180,233],"125":[15,66,114,124,137,181,234],"and":[16,54,73,115,235,317],"TPS":[17,74,116,149,197,207,224,236],"were":[18,28,85,117],"good":[19],"markers":[20],"for":[21,30,50,58],"clinical":[22],"outcome":[23],"prediction.":[24],"Patients":[25],"receiving":[26],"chemotherapy":[27,83,189],"analyzed":[29],"2-year":[31],"overall":[32],"(OS).":[34],"Kaplan-Meier":[35],"showed":[38,304],"highly":[39],"significant":[40],"differences":[41],"in":[42,91,101,310],"OS":[43,90,311,322],"between":[44,312],"stage":[47,55,92,107],"I+II":[48,93],"(survival":[49,57],"2":[51,59,289],"years":[52,60,290],"68%)":[53],"III+IV":[56,108],"33%;":[61],"p":[62],"=":[63,96,192,273,302,327],"0.0008).":[64],"levels":[67,75,111,125,138,150,161,182,198,208,225,249],"above":[68,76,139,162,226,267],"or":[69,77],"below":[70,78,126,151,209,250],"35":[71,185],"kU/I":[72,186],"80":[79],"U/l":[80],"after":[81,187],"3":[82,188],"courses":[84,190],"not":[86,331],"significantly":[87,332],"correlated":[88,242,286,333],"(p":[95,145,171,272,326],"0.06":[97],"respectively":[98],"0.07).":[99],"However,":[100],"the":[102,109,127,131,140,152,156,163,168,175,203,210,214,220,227,256,268,279,288,295],"subgroup":[103],"cut-off":[110,128,141,153,164,211,237,270],"excellent":[118],"discriminators":[119],"OS:":[121],"With":[122,148,206,248],"52%":[129],"survived,":[133,158,216,258],"while":[134,159,217,259],"only":[142,165,262],"13%":[143],"survived":[144,170,222],"<":[146,172],"0.0001).":[147,173],"49%":[154],"19%":[166],"In":[174],"subset":[176],"less":[183],"than":[184],"(n":[191,301],"50)":[193],"their":[196],"allowed":[199],"further":[200],"discrimination":[201],"prognostic":[204],"significance.":[205],"63%":[212,254],"35%":[218],"cut-off.":[228],"sum":[230,252,265],"value":[231,253],"values":[238,266],"(115)":[239],"as":[240],"discriminator":[241],"even":[243],"better":[244],"rate:":[247],"this":[251,260],"was":[261,281,320,330],"17%":[263],"summed":[269],"level":[271],"0.0004).":[274],"extent":[276],"to":[277],"which":[278],"tumor":[280],"removed":[282],"at":[283],"operation":[284],"also":[285],"rate.":[292],"None":[293],"a":[298,305],"staging":[299],"laparotomy":[300],"10)":[303],"2-years":[306],"survival.":[307],"difference":[309],"complete":[315],"debulking":[316,319],"partial":[318],"significant:":[321],"51%":[323],"versus":[324],"23%":[325],"0.027).":[328],"Prognosis":[329],"histological":[335],"type.":[336]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}